Similar articles for PMID: 11520781

Year	Number of Results
1976	1
1983	1
1984	1
1988	1
1989	1
1990	2
1995	2
1996	11
1997	9
1998	15
1999	13
2000	12
2001	4
2002	8
2003	2
2004	2
2005	2
2006	1
2007	3
2008	3
2009	1
2010	4
2011	2
2012	13
2013	10
2014	4
2015	3
2016	1
2017	5
2018	5
2019	6
2020	21
2021	29
2022	28
2023	13
2024	2

1

Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin.

Goodnough LT, Kuter DJ, McCullough J, Slichter SJ, DiPersio J, Romo J, Peterson R, Smith KJ, Raife T, Tomita D, Armstrong S. Goodnough LT, et al. Blood. 2001 Sep 1;98(5):1346-51. doi: 10.1182/blood.v98.5.1346. Blood. 2001. PMID: 11520781 Free article. Clinical Trial.

2

Thrombopoietin therapy increases platelet yields in healthy platelet donors.

Kuter DJ, Goodnough LT, Romo J, DiPersio J, Peterson R, Tomita D, Sheridan W, McCullough J. Kuter DJ, et al. Blood. 2001 Sep 1;98(5):1339-45. doi: 10.1182/blood.v98.5.1339. Blood. 2001. PMID: 11520780 Free article. Clinical Trial.

3

The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation.

Schuster MW, Beveridge R, Frei-Lahr D, Abboud CN, Cruickshank S, Macri M, Menchaca D, Holden J, Waller EK. Schuster MW, et al. Exp Hematol. 2002 Sep;30(9):1044-50. doi: 10.1016/s0301-472x(02)00878-0. Exp Hematol. 2002. PMID: 12225796 Free article. Clinical Trial.

4

The use of PEG-rhuMGDF in platelet apheresis.

Kuter DJ. Kuter DJ. Stem Cells. 1998;16 Suppl 2:231-42. doi: 10.1002/stem.5530160726. Stem Cells. 1998. PMID: 11012195 Review.

5

Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer.

Basser RL, Rasko JE, Clarke K, Cebon J, Green MD, Grigg AP, Zalcberg J, Cohen B, O'Byrne J, Menchaca DM, Fox RM, Begley CG. Basser RL, et al. Blood. 1997 May 1;89(9):3118-28. Blood. 1997. PMID: 9129014 Free article. Clinical Trial.

6

Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia--a randomized, placebo-controlled, double-blind safety and efficacy study.

Geissler K, Yin JA, Ganser A, Sanz MA, Szer J, Raghavachar A, Hoelzer D, Martinez C, Taylor K, Kanz L, To LB, Archimbaud E. Geissler K, et al. Ann Hematol. 2003 Nov;82(11):677-83. doi: 10.1007/s00277-003-0737-7. Epub 2003 Oct 3. Ann Hematol. 2003. PMID: 14530872 Clinical Trial.

7

Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer.

Basser RL, Rasko JE, Clarke K, Cebon J, Green MD, Hussein S, Alt C, Menchaca D, Tomita D, Marty J, Fox RM, Begley CG. Basser RL, et al. Lancet. 1996 Nov 9;348(9037):1279-81. doi: 10.1016/S0140-6736(96)04471-6. Lancet. 1996. PMID: 8909381 Clinical Trial.

8

A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemia.

Schiffer CA, Miller K, Larson RA, Amrein PC, Antin JH, Zani VJ, Stone RM. Schiffer CA, et al. Blood. 2000 Apr 15;95(8):2530-5. Blood. 2000. PMID: 10753831 Free article. Clinical Trial.

9

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.

Desborough M, Estcourt LJ, Doree C, Trivella M, Hopewell S, Stanworth SJ, Murphy MF. Desborough M, et al. Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD010982. doi: 10.1002/14651858.CD010982.pub2. Cochrane Database Syst Rev. 2016. PMID: 27548292 Free PMC article. Review.

10

Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.

Harker LA, Marzec UM, Kelly AB, Cheung E, Tomer A, Nichol JL, Hanson SR, Stead RB. Harker LA, et al. Blood. 1997 Jan 1;89(1):155-65. Blood. 1997. PMID: 8978288 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

217 results

Results by year